Maravai LifeSciences Holdings Inc (MRVI)
8.96
-0.05
(-0.55%)
USD |
NASDAQ |
May 07, 16:00
8.96
0.00 (0.00%)
After-Hours: 20:00
Maravai LifeSciences Holdings Cash from Financing (Quarterly): 0.47M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.47M |
| September 30, 2023 | 0.783M |
| June 30, 2023 | -43.13M |
| March 31, 2023 | -19.21M |
| December 31, 2022 | -66.12M |
| September 30, 2022 | -37.44M |
| June 30, 2022 | -43.41M |
| March 31, 2022 | -40.52M |
| Date | Value |
|---|---|
| December 31, 2021 | -49.58M |
| September 30, 2021 | -51.28M |
| June 30, 2021 | -34.13M |
| March 31, 2021 | -24.06M |
| December 31, 2020 | 40.67M |
| September 30, 2020 | -0.943M |
| June 30, 2020 | -0.856M |
| March 31, 2020 | 14.34M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-66.12M
Minimum
Dec 2022
40.67M
Maximum
Dec 2020
-22.15M
Average
-29.09M
Median
Cash from Financing (Quarterly) Benchmarks
| ModivCare Inc | 6.38M |
| Dyadic International Inc | 0.00 |
| Enveric Biosciences Inc | -0.1861M |
| Monopar Therapeutics Inc | 0.3345M |
| SeaStar Medical Holding Corp | 4.588M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 7.79M |
| Cash from Investing (Quarterly) | -12.90M |
| Free Cash Flow | 60.67M |
| Free Cash Flow Per Share (Quarterly) | -0.0682 |
| Free Cash Flow to Equity (Quarterly) | -8.196M |
| Free Cash Flow to Firm (Quarterly) | -10.34M |
| Free Cash Flow Yield | 5.13% |